Doctors investigate commonly used medications that may worsen COVID-19, or even help fight it
A study has found there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen […]
Read More.
Articles by Author: Elise
Author: Elise
Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer
Researchers are exploring the use of experimental medication to prevent heart disease for chemo-resistant ovarian cancer
Read More.Top 10 Blockchain Predictions for the (Near) Future of Healthcare
Blockchain in Healthcare Today (BHTY) asked the world’s blockchain in healthcare experts to share their insights. Here, our internationally-renowned BHTY peer-review board discusses their major predictions.
Read More.The Impact of Blockchain on Medical Tourism
In this conceptual paper, we investigate the potential benefits of Blockchain technology to address some of the open questions in medical tourism.
Read More.New drug combination could support better cancer treatments
Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.
Read More.Could cancer immunotherapy success depend on gut bacteria?
A study by researchers at UT Southwestern Medical Center and the University of Chicago suggests that gut bacteria can penetrate tumour cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.
Read More.Select Effective Disinfectants for Use Against the Coronavirus That Causes COVID-19
Source and credit: Infection Control Today® (ICT) By Richard Lowe, PhD, MPH Reference: Lowe, R. (2020) ‘Select Effective Disinfectants for […]
Read More.Scientists developing new vaccine approach for most aggressive brain cancer
Scientists are developing a combined vaccine to fight the most deadly form of brain cancer.
Read More.Extra chromosomes in cancers can be good or bad
Some advanced tumours can harbour cells that have accumulated more than 100 chromosomes, instead of 46 in normal cells. High levels of aneuploidy are associated with aggressive cancers and a poor prognosis for patients. But according to Cold Spring Harbor Laboratory investigator Jason Sheltzer and colleagues, not all aneuploidies spur cancer’s progression.
Read More.CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord […]
Read More.
